quinacrine has been researched along with Myelodysplastic Syndromes in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohyashiki, K | 1 |
| Kodama, A | 1 |
| Ohyashiki, JH | 1 |
| Gordon, N | 1 |
| Thom, J | 1 |
| Cole, C | 1 |
| Baker, R | 1 |
2 other studies available for quinacrine and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Cytogenetics in myelodysplastic syndromes.
Topics: Azure Stains; Cell Culture Techniques; Chromosome Banding; Chromosomes, Human; Cytogenetic Analysis; | 2011 |
Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelet Disorders; Cell Separation; Diagnosis, Differential; | 1995 |